Development of a contacting transwell co-culture system for the

HGF NFAT NFkB PCNSL Pin1 lymphoma pericytes vitrigel

Journal

Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250

Informations de publication

Date de publication:
2023
Historique:
received: 10 08 2023
accepted: 31 10 2023
medline: 13 12 2023
pubmed: 13 12 2023
entrez: 13 12 2023
Statut: epublish

Résumé

Primary central nervous system lymphoma (PCNSL) is a malignant neoplasm of the central nervous system that is refractory to treatment and has extremely poor prognosis. One factor hindering the development of therapeutic options for PCNSL is its molecular heterogeneity and the extreme difficulty in establishing

Identifiants

DOI: 10.3389/fcell.2023.1275519 PMID: 38089883 PMC: PMC10712316
pubmed: 38089883
doi: 10.3389/fcell.2023.1275519
pii: 1275519
pmc: PMC10712316
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1275519

Informations de copyright

Copyright © 2023 Nishi, Tateishi, Sundararaj, Ino, Nakai, Hatayama, Yamaoka, Mihana, Miyakawa, Kimura, Kimura, Yamamoto and Ryo.

Déclaration de conflit d'intérêts

Authors YY and YM were employed by Kanto Chemical Co., Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Mayuko Nishi (M)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Department of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

Kensuke Tateishi (K)

Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Laboratory of Biopharmaceutical and Regenerative Science, Graduate School of Medical Science, Yokohama City University, Yokohama, Japan.

Jeremiah Stanleyraj Sundararaj (JS)

Department of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

Yoko Ino (Y)

Advanced Medical Research Center, Yokohama City University, Yokohama, Japan.

Yusuke Nakai (Y)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Department of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

Yasuyoshi Hatayama (Y)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Department of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

Yutaro Yamaoka (Y)

Department of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Tokyo, Japan.

Yusaku Mihana (Y)

Department of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Tokyo, Japan.

Kei Miyakawa (K)

Department of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.
Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan.

Hirokazu Kimura (H)

Department of Health Science, Gunma Paz University Graduate School of Health Sciences, Takasaki-shi, Japan.

Yayoi Kimura (Y)

Advanced Medical Research Center, Yokohama City University, Yokohama, Japan.

Tetsuya Yamamoto (T)

Department of Neurosurgery, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

Akihide Ryo (A)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Department of Microbiology, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

Classifications MeSH